Meridian Investment Counsel’s Amgen AMGN Stock Holding History

Meridian Investment Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53M	Sell	6,995 -45	-0.6%	-$15.4K	0.54%	58
2026 Q1	$2.48M	Hold	7,040	–	–	0.59%	53
2025 Q4	$2.3M	Hold	7,040	–	–	0.56%	56
2025 Q3	$1.99M	Hold	7,040	–	–	0.49%	65
2025 Q2	$1.97M	Buy	7,040 +273	+4%	+$77.3K	0.53%	58
2025 Q1	$2.11M	Hold	6,767	–	–	0.62%	51
2024 Q4	$1.76M	Hold	6,767	–	–	0.53%	56
2024 Q3	$2.18M	Sell	6,767 -300	-4%	-$98.1K	0.66%	43
2024 Q2	$2.21M	Hold	7,067	–	–	0.7%	41
2024 Q1	$2.01M	Sell	7,067 -83	-1%	-$24.3K	0.67%	45
2023 Q4	$2.06M	Hold	7,150	–	–	0.71%	42
2023 Q3	$1.92M	Sell	7,150 -100	-1%	-$25K	0.72%	41
2023 Q2	$1.61M	Sell	7,250 -107	-1%	-$24.8K	0.57%	51
2023 Q1	$1.78M	Hold	7,357	–	–	0.68%	44
2022 Q4	$1.93M	Sell	7,357 -225	-3%	-$60.3K	0.77%	38
2022 Q3	$1.71M	Sell	7,582 -275	-4%	-$66.7K	0.76%	37
2022 Q2	$1.91M	Sell	7,857 -100	-1%	-$24.5K	0.79%	38
2022 Q1	$1.92M	Hold	7,957	–	–	0.67%	39
2021 Q4	$1.79M	Sell	7,957 -171	-2%	-$36.1K	0.59%	46
2021 Q3	$1.73M	Hold	8,128	–	–	0.63%	43
2021 Q2	$1.98M	Buy	8,128 +695	+9%	+$171K	0.7%	37
2021 Q1	$1.85M	Hold	7,433	–	–	0.71%	37
2020 Q4	$1.71M	Hold	7,433	–	–	0.72%	36
2020 Q3	$1.89M	Sell	7,433 -500	-6%	-$124K	0.92%	30
2020 Q2	$1.87M	Hold	7,933	–	–	0.96%	31
2020 Q1	$1.61M	Sell	7,933 -225	-3%	-$49.1K	1.04%	28
2019 Q4	$1.97M	Hold	8,158	–	–	0.97%	29
2019 Q3	$1.58M	Hold	8,158	–	–	0.86%	35
2019 Q2	$1.5M	Buy	8,158 +207	+3%	+$37.1K	0.83%	38
2019 Q1	$1.51M	Hold	7,951	–	–	0.88%	35
2018 Q4	$1.55M	Hold	7,951	–	–	1.02%	33
2018 Q3	$1.65M	Buy	7,951 +75	+1%	+$14.8K	0.9%	35
2018 Q2	$1.45M	Buy	7,876 +200	+3%	+$35.4K	0.82%	38
2018 Q1	$1.31M	Buy	7,676 +325	+4%	+$59.7K	0.74%	44
2017 Q4	$1.28M	Hold	7,351	–	–	0.69%	45
2017 Q3	$1.37M	Hold	7,351	–	–	0.79%	41
2017 Q2	$1.27M	Hold	7,351	–	–	0.76%	44
2017 Q1	$1.21M	Hold	7,351	–	–	0.74%	46
2016 Q4	$1.07M	Sell	7,351 -350	-5%	-$52.7K	0.72%	47
2016 Q3	$1.28M	Buy	7,701 +200	+3%	+$33.8K	0.86%	38
2016 Q2	$1.14M	Hold	7,501	–	–	0.78%	43
2016 Q1	$1.13M	Buy	7,501 +25	+0.3%	+$3.71K	0.79%	40
2015 Q4	$1.21M	Sell	7,476 -50	-0.7%	-$7.86K	0.89%	36
2015 Q3	$1.04M	Sell	7,526 -900	-11%	-$142K	0.85%	40
2015 Q2	$1.29M	Sell	8,426 -339	-4%	-$54.3K	0.93%	36
2015 Q1	$1.4M	Buy	8,765 +464	+6%	+$73.1K	0.97%	35
2014 Q4	$1.32M	Hold	8,301	–	–	0.96%	34
2014 Q3	$1.17M	Hold	8,301	–	–	0.87%	40
2014 Q2	$983K	Buy	8,301 +5	+0.1%	+$579	0.76%	45
2014 Q1	$1.02M	Sell	8,296 -464	-5%	-$56.3K	0.87%	39
2013 Q4	$999K	Buy	+8,760	New	+$996K	0.85%	39

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Meridian Investment Counsel's AMGN Position: Q2 2026 in Review

Meridian Investment Counsel reduced its Amgen (AMGN) stake by 0.64% in Q2 2026, selling an estimated $15.4K and leaving 6,995 shares worth $2.53M. The position accounts for 0.54% of the portfolio, ranked #58.

Meridian Investment Counsel first reported a position in AMGN in Q4 2013 and has held it in 51 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Meridian Investment Counsel held 6,995 shares of Amgen worth $2.53M as of Q2 2026.
Meridian Investment Counsel sold 45 Amgen shares in Q2 2026, an estimated $15.4K.
Amgen made up 0.54% of Meridian Investment Counsel's portfolio in Q2 2026, its #58 holding.
Meridian Investment Counsel first reported a position in Amgen in Q4 2013 and has held it in 51 quarters since.
1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.